These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19075639)

  • 1. A review article: sevelamer hydrochloride and metabolic acidosis in dialysis patients.
    Oka Y; Miyazaki M; Takatsu S; Oohara T; Toda K; Uno F; Matsuda H
    Cardiovasc Hematol Disord Drug Targets; 2008 Dec; 8(4):283-6. PubMed ID: 19075639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevelamer hydrochloride dose-dependent increase in prevalence of severe acidosis in hemodialysis patients: analysis of nationwide statistical survey in Japan.
    Oka Y; Miyazaki M; Matsuda H; Takatsu S; Katsube R; Mori T; Takehara K; Umeda Y; Uno F
    Ther Apher Dial; 2014 Feb; 18(1):37-43. PubMed ID: 24499082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sevelamer hydrochloride exacerbates metabolic acidosis in hemodialysis patients, depending on the dosage.
    Oka Y; Miyazaki M; Takatsu S; Kunitomo K; Uno F; Maruyama M; Matsuda H
    Ther Apher Dial; 2007 Apr; 11(2):107-13. PubMed ID: 17381531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of sevelamer hydrochloride and sevelamer carbonate: risk of metabolic acidosis and clinical implications.
    Pai AB; Shepler BM
    Pharmacotherapy; 2009 May; 29(5):554-61. PubMed ID: 19397463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sevelamer hydrochloride in peritoneal dialysis patients: results of a multicenter cross-sectional study.
    Ramos R; Moreso F; Borras M; Ponz E; Buades JM; Teixidó J; Morey A; Garcia C; Vera M; Doñate MT; de Arellano MR; Barbosa F; González MT
    Perit Dial Int; 2007; 27(6):697-701. PubMed ID: 17984434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sevelamer worsens metabolic acidosis in hemodialysis patients.
    De Santo NG; Frangiosa A; Anastasio P; Marino A; Correale G; Perna A; Di Stazio E; Stellato D; Santoro D; Di Meglio E; Iacono G; Ciacci C; Savica V; Cirillo M
    J Nephrol; 2006; 19 Suppl 9():S108-14. PubMed ID: 16736432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switching hemodialysis patients from sevelamer hydrochloride to bixalomer: a single-center, non-randomized analysis of efficacy and effects on gastrointestinal symptoms and metabolic acidosis.
    Hatakeyama S; Murasawa H; Narita T; Oikawa M; Fujita N; Iwamura H; Mikami J; Kojima Y; Sato T; Fukushi K; Ishibashi Y; Hashimoto Y; Koie T; Saitoh H; Funyu T; Ohyama C
    BMC Nephrol; 2013 Oct; 14():222. PubMed ID: 24119202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buffering effects of calcium carbonate as clarified by sevelamer hydrochloride monotherapy.
    Akatsuka T; Mochizuki T; Koike T
    Ther Apher Dial; 2008 Jun; 12(3):216-25. PubMed ID: 18503699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphate binders and metabolic acidosis in patients undergoing maintenance hemodialysis—sevelamer hydrochloride, calcium carbonate, and bixalomer.
    Sanai T; Tada H; Ono T; Fukumitsu T
    Hemodial Int; 2015 Jan; 19(1):54-9. PubMed ID: 24980286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications.
    Brezina B; Qunibi WY; Nolan CR
    Kidney Int Suppl; 2004 Sep; (90):S39-45. PubMed ID: 15296506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term management of sevelamer hydrochloride-induced metabolic acidosis aggravation and hyperkalemia in hemodialysis patients.
    Sonikian M; Metaxaki P; Iliopoulos A; Marioli S; Vlassopoulos D
    Ren Fail; 2006; 28(5):411-8. PubMed ID: 16825091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of sevelamer hydrochloride and calcium-based phosphate binders on mortality in hemodialysis patients: a need for more research.
    Assimon MM; Mousa S; Shaker O; Pai AB
    Consult Pharm; 2010 Jan; 25(1):41-54. PubMed ID: 20211816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of SBR759, a novel calcium-free, iron(III)-based phosphate binder, in Asian patients undergoing hemodialysis: A 12-week, randomized, open-label, dose-titration study versus sevelamer hydrochloride.
    Chen JB; Chiang SS; Chen HC; Obayashi S; Nagasawa M; Hexham JM; Balfour A; Junge G; Akiba T; Fukagawa M
    Nephrology (Carlton); 2011 Nov; 16(8):743-50. PubMed ID: 21854503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal dialysis patients using sevelamer do not present the acidosis problems that hemodialysis patients do.
    Pagé D; Knoll G
    Adv Perit Dial; 2005; 21():185-7. PubMed ID: 16686315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term comparison of sevelamer hydrochloride to calcium-containing phosphate binders.
    Brewster UC; Ciampi MA; Abu-Alfa AK; Reilly RF
    Nephrology (Carlton); 2006 Apr; 11(2):142-6. PubMed ID: 16669977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
    Delmez J; Block G; Robertson J; Chasan-Taber S; Blair A; Dillon M; Bleyer AJ
    Clin Nephrol; 2007 Dec; 68(6):386-91. PubMed ID: 18184521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical effects of the new phosphorus binder, bixalomer in hemodialysis patients switched from sevelamer hydrochloride.
    Gen S; Sasaki T; Saito K; Nobe K; Nodaira Y; Ikeda N
    Ther Apher Dial; 2014 Jun; 18 Suppl 2():8-12. PubMed ID: 24975889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of sevelamer hydrochloride with calcium acetate on biomarkers of bone turnover in hemodialysis patients.
    Liu YL; Lin HH; Yu CC; Kuo HL; Yang YF; Chou CY; Lin PW; Liu JH; Liao PY; Huang CC
    Ren Fail; 2006; 28(8):701-7. PubMed ID: 17162430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients.
    Tonelli M; Wiebe N; Culleton B; Lee H; Klarenbach S; Shrive F; Manns B;
    Nephrol Dial Transplant; 2007 Oct; 22(10):2856-66. PubMed ID: 17906326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
    Evenepoel P; Selgas R; Caputo F; Foggensteiner L; Heaf JG; Ortiz A; Kelly A; Chasan-Taber S; Duggal A; Fan S
    Nephrol Dial Transplant; 2009 Jan; 24(1):278-85. PubMed ID: 18820280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.